Long-term patient reported outcomes and hematologic toxicity among patients who received Granulocyte-Colony Stimulating Factors during chemotherapy for early breast cancer

Long-term patient reported outcomes and hematologic toxicity among patients who received Granulocyte-Colony Stimulating Factors during chemotherapy for early breast cancer

We assessed long-term associations of Granulocyte-Colony Stimulating Factors (G-CSF) use with patient-reported outcomes (PROs) and hematologic toxicity among chemotherapy-treated, early-stage breast cancer patients in CANTO (NCT01993498).Among 2920 patients longitudinally followed-up until year-4 af...

Full description

Bibliographic Details
Main Authors: Pietro Lapidari, Arnauld Gbenou, Julie Havas, Elise Martin, Barbara Pistilli, Anne-Laure Martin, Sibille Everhard, Charles Coutant, Paul Cottu, Anne Lesur, Florence Lerebours, Olivier Tredan, Laurence Vanlemmens, Christelle Jouannaud, Christelle Levy, Olivier Rigal, Marion Fournier, Fabrice Andre, Ines Vaz-Luis, Antonio Di Meglio
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Breast
Subjects:
Breast cancer
Survivorship
Granulocyte-colony stimulating factors
Health-related quality-of-life
Patient-reported outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S096097762100028X

Internet

http://www.sciencedirect.com/science/article/pii/S096097762100028X

Similar Items